Abaloparatide (TFA)
Abaloparatide TFA (BA 058 TFA) is a parathyroid hormone receptor 1 (PTHR1) analogue. Abaloparatide TFA also is a selective PTHR1 activator. Abaloparatide TFA enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide TFA enhances bone formation and cortical structure in mice. Abaloparatide TFA has the potential for the research of osteoporosis[1][2].
Product Specifications
Product Name Alternative
BA 058 (TFA) ; BIM 44058 (TFA)
UNSPSC
12352209
Target
Arrestin; PTHR
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Endocrinology; Cancer
Assay Protocol
https://www.medchemexpress.com/abaloparatide-tfa.html
Purity
99.51
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C176H301N56F3O51
Molecular Weight
4074.61
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-108742A/Abaloparatide-TFA-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-108742A/Abaloparatide-TFA-SDS-MedChemExpress.pdf
Scientific Category
Peptides
Clinical Information
Launched
Citation 01
Proc Natl Acad Sci U S A. 2021 Nov 9;118 (45) :e2107363118.|BMC Oral Health. 2025 Sep 29;25 (1) :1492.
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items